| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.52B | 38.08B | 35.10B | 34.70B | 38.09B | 36.12B |
| Gross Profit | 3.59B | 3.97B | 3.54B | 3.41B | 3.82B | 3.53B |
| EBITDA | 4.17B | 4.57B | 4.00B | 3.73B | 4.02B | 3.59B |
| Net Income | 1.22B | 1.47B | 1.13B | 980.00M | 1.27B | 1.13B |
Balance Sheet | ||||||
| Total Assets | 50.52B | 56.01B | 50.99B | 48.44B | 46.31B | 47.58B |
| Cash, Cash Equivalents and Short-Term Investments | 3.91B | 4.41B | 4.89B | 2.66B | 2.92B | 3.83B |
| Total Debt | 16.08B | 16.96B | 16.25B | 14.06B | 14.89B | 16.55B |
| Total Liabilities | 22.79B | 25.16B | 23.46B | 21.88B | 22.42B | 24.70B |
| Stockholders Equity | 27.54B | 30.64B | 27.35B | 26.40B | 23.74B | 22.73B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -513.00M | -821.00M | 951.00M | -100.00M | -3.22B |
| Operating Cash Flow | 0.00 | 3.26B | 2.15B | 2.60B | 4.18B | 2.79B |
| Investing Cash Flow | 0.00 | -3.51B | -2.22B | -1.10B | -4.18B | -5.94B |
| Financing Cash Flow | 0.00 | -244.00M | 2.29B | -1.76B | -945.00M | 3.68B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥92.08B | 13.21 | ― | 3.48% | 1.42% | 32.92% | |
70 Outperform | ¥13.76B | 8.77 | ― | 3.85% | 8.49% | 32.73% | |
67 Neutral | ¥71.07B | 10.57 | ― | 3.63% | 0.60% | 10.27% | |
65 Neutral | ¥13.43B | 9.02 | ― | 3.04% | 3.34% | 11.67% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥296.19B | 26.28 | ― | 1.28% | 6.67% | 10.43% | |
59 Neutral | ¥286.11B | 16.28 | ― | 2.94% | 1.47% | -10.54% |